Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

464 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intracameral bevacizumab for iris rubeosis.
Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU; Tuebingen Bevacizumab Study Group. Grisanti S, et al. Am J Ophthalmol. 2006 Jul;142(1):158-60. doi: 10.1016/j.ajo.2006.02.045. Am J Ophthalmol. 2006. PMID: 16815268
Bevacizumab: off-label use in ophthalmology.
Grisanti S, Ziemssen F. Grisanti S, et al. Indian J Ophthalmol. 2007 Nov-Dec;55(6):417-20. doi: 10.4103/0301-4738.36474. Indian J Ophthalmol. 2007. PMID: 17951896 Free PMC article. Review.
Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.
Yoeruek E, Ziemssen F, Henke-Fahle S, Tatar O, Tura A, Grisanti S, Bartz-Schmidt KU, Szurman P; Tübingen Bevacizumab Study Group. Yoeruek E, et al. Among authors: grisanti s. Acta Ophthalmol. 2008 May;86(3):322-8. doi: 10.1111/j.1600-0420.2007.01049.x. Epub 2007 Nov 8. Acta Ophthalmol. 2008. PMID: 17995975 Free article.
Intensified monitoring of circadian blood pressure and heart rate before and after intravitreous injection of bevacizumab: preliminary findings of a pilot study.
Ziemssen F, Zhu Q, Peters S, Grisanti S, El Wardani M, Szurman P, Bartz-Schmidt KU; Tuebingen Bevacizumab Study Group; Ziemssen T. Ziemssen F, et al. Among authors: grisanti s. Int Ophthalmol. 2009 Aug;29(4):213-24. doi: 10.1007/s10792-008-9221-7. Epub 2008 Apr 17. Int Ophthalmol. 2009. PMID: 18418553
464 results